Frank DH - Search Results

1

Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ.

Frank DH, Davis JR, Alberts DS, Thompson D, Liu Y, Bartels PH. Frank DH, et al. Anal Quant Cytol Histol. 2001 Dec;23(6):418-26. Anal Quant Cytol Histol. 2001. PMID: 11777277

2

Karyometry of infiltrating breast lesions.

Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH. Frank DH, et al. Anal Quant Cytol Histol. 2005 Aug;27(4):195-201. Anal Quant Cytol Histol. 2005. PMID: 16220830

3

Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.

Bartels PH, Fabian CJ, Kimler BF, Ranger-Moore JR, Frank DH, Yozwiak ML, Alberts DS. Bartels PH, et al. Among authors: frank dh. Anal Quant Cytol Histol. 2007 Apr;29(2):63-70. Anal Quant Cytol Histol. 2007. PMID: 17484269

4

Malignancy-associated changes in lactiferous duct epithelium.

Anderson N, Houghton J, Kirk SJ, Frank D, Ranger-Moore J, Alberts DS, Thompson D, Bartels PH. Anderson N, et al. Anal Quant Cytol Histol. 2003 Apr;25(2):63-72. Anal Quant Cytol Histol. 2003. PMID: 12746974

5

Karyometry in rectal mucosa of patients with previous colorectal adenomas.

Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH. Ranger-Moore J, et al. Anal Quant Cytol Histol. 2005 Jun;27(3):134-42. Anal Quant Cytol Histol. 2005. PMID: 16121634 Clinical Trial.

6

Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.

Frank DH, Kimler BF, Fabian CJ, Ranger-Moore J, Yozwiak M, Bartels HG, Alberts DS, Bartels PH. Frank DH, et al. Breast Cancer Res Treat. 2009 Jun;115(3):661-8. doi: 10.1007/s10549-008-0274-0. Epub 2009 Jan 6. Breast Cancer Res Treat. 2009. PMID: 19125322 Clinical Trial.

7

Quantitative study of breast cancer progression: different pathways for various in situ cancers.

Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH. Mariuzzi L, et al. Mod Pathol. 2002 Jan;15(1):18-25. doi: 10.1038/modpathol.3880485. Mod Pathol. 2002. PMID: 11796837

8

Karyometry in the early detection and chemoprevention of intraepithelial lesions.

Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH. Ranger-Moore J, et al. Eur J Cancer. 2005 Sep;41(13):1875-88. doi: 10.1016/j.ejca.2005.07.002. Eur J Cancer. 2005. PMID: 16087328

9

Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography.

Chow HH, Anavy N, Salazar D, Frank DH, Alberts DS. Chow HH, et al. Among authors: frank dh. J Pharm Biomed Anal. 2004 Jan 27;34(1):167-74. doi: 10.1016/j.japna.2003.08.018. J Pharm Biomed Anal. 2004. PMID: 14738931

10

Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.

Frank DH, Roe DJ, Chow HH, Guillen JM, Choquette K, Gracie D, Francis J, Fish A, Alberts DS. Frank DH, et al. Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):299-303. doi: 10.1158/1055-9965.epi-03-0163. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14973093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters